BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 37358849)

  • 1. Association of Statin Use With Risk of Liver Disease, Hepatocellular Carcinoma, and Liver-Related Mortality.
    Vell MS; Loomba R; Krishnan A; Wangensteen KJ; Trebicka J; Creasy KT; Trautwein C; Scorletti E; Seeling KS; Hehl L; Rendel MD; Zandvakili I; Li T; Chen J; Vujkovic M; Alqahtani S; Rader DJ; Schneider KM; Schneider CV
    JAMA Netw Open; 2023 Jun; 6(6):e2320222. PubMed ID: 37358849
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of statin on hepatocellular carcinoma in patients with type 2 diabetes: A nationwide nested case-control study.
    Kim G; Jang SY; Han E; Lee YH; Park SY; Nam CM; Kang ES
    Int J Cancer; 2017 Feb; 140(4):798-806. PubMed ID: 27861855
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lipophilic Statins and Risk for Hepatocellular Carcinoma and Death in Patients With Chronic Viral Hepatitis: Results From a Nationwide Swedish Population.
    Simon TG; Duberg AS; Aleman S; Hagstrom H; Nguyen LH; Khalili H; Chung RT; Ludvigsson JF
    Ann Intern Med; 2019 Sep; 171(5):318-327. PubMed ID: 31426090
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Statin use and the risk of hepatocellular carcinoma in patients at high risk: A nationwide nested case-control study.
    Kim G; Jang SY; Nam CM; Kang ES
    J Hepatol; 2018 Mar; 68(3):476-484. PubMed ID: 29107150
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Statins Are Associated With a Decreased Risk of Severe Liver Disease in Individuals With Noncirrhotic Chronic Liver Disease.
    Sharma R; Simon TG; Hagström H; Lochhead P; Roelstraete B; Söderling J; Verna EC; Emond J; Ludvigsson JF
    Clin Gastroenterol Hepatol; 2024 Apr; 22(4):749-759.e19. PubMed ID: 37121528
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Statin use is associated with a lower risk of recurrence after curative resection in BCLC stage 0-A hepatocellular carcinoma.
    Yang SY; Wang CC; Chen KD; Liu YW; Lin CC; Chuang CH; Tsai YC; Yao CC; Yen YH; Hsiao CC; Hu TH; Tsai MC
    BMC Cancer; 2021 Jan; 21(1):70. PubMed ID: 33446127
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Statins, risk of diabetes, and implications on outcomes in the general population.
    Wang KL; Liu CJ; Chao TF; Huang CM; Wu CH; Chen SJ; Chen TJ; Lin SJ; Chiang CE
    J Am Coll Cardiol; 2012 Oct; 60(14):1231-8. PubMed ID: 22884288
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Synergistic Associations of PNPLA3 I148M Variant, Alcohol Intake, and Obesity With Risk of Cirrhosis, Hepatocellular Carcinoma, and Mortality.
    Kim HS; Xiao X; Byun J; Jun G; DeSantis SM; Chen H; Thrift AP; El-Serag HB; Kanwal F; Amos CI
    JAMA Netw Open; 2022 Oct; 5(10):e2234221. PubMed ID: 36190732
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association of Statin Therapy With Prevention of Vision-Threatening Diabetic Retinopathy.
    Kang EY; Chen TH; Garg SJ; Sun CC; Kang JH; Wu WC; Hung MJ; Lai CC; Cherng WJ; Hwang YS
    JAMA Ophthalmol; 2019 Apr; 137(4):363-371. PubMed ID: 30629109
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Higher cholesterol levels, not statin use, are associated with a lower risk of hepatocellular carcinoma.
    Yi SW; Kim SH; Han KJ; Yi JJ; Ohrr H
    Br J Cancer; 2020 Mar; 122(5):630-633. PubMed ID: 31857717
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Statin and the risk of hepatocellular carcinoma and death in a hospital-based hepatitis B-infected population: A propensity score landmark analysis.
    Hsiang JC; Wong GL; Tse YK; Wong VW; Yip TC; Chan HL
    J Hepatol; 2015 Nov; 63(5):1190-7. PubMed ID: 26208777
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of perioperative use of statins, metformin, and aspirin with recurrence after curative liver resection in patients with hepatocellular carcinoma: A propensity score matching analysis.
    Khajeh E; Aminizadeh E; Moghadam AD; Ramouz A; Klotz R; Golriz M; Merle U; Springfeld C; Chang DH; Longerich T; Büchler MW; Mehrabi A
    Cancer Med; 2023 Oct; 12(19):19548-19559. PubMed ID: 37737550
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of Statin Therapy With Major Adverse Cardiovascular and Limb Outcomes in Patients With End-stage Kidney Disease and Peripheral Artery Disease Receiving Maintenance Dialysis.
    Lo HY; Lin YS; Lin DS; Lee JK; Chen WJ
    JAMA Netw Open; 2022 Sep; 5(9):e2229706. PubMed ID: 36048442
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of Statin Use With Cancer- and Noncancer-Associated Survival Among Patients With Breast Cancer in Asia.
    Chang WT; Lin HW; Lin SH; Li YH
    JAMA Netw Open; 2023 Apr; 6(4):e239515. PubMed ID: 37083661
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Atorvastatin and fluvastatin are associated with dose-dependent reductions in cirrhosis and hepatocellular carcinoma, among patients with hepatitis C virus: Results from ERCHIVES.
    Simon TG; Bonilla H; Yan P; Chung RT; Butt AA
    Hepatology; 2016 Jul; 64(1):47-57. PubMed ID: 26891205
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association Between Aspirin Use and Risk of Hepatocellular Carcinoma.
    Simon TG; Ma Y; Ludvigsson JF; Chong DQ; Giovannucci EL; Fuchs CS; Meyerhardt JA; Corey KE; Chung RT; Zhang X; Chan AT
    JAMA Oncol; 2018 Dec; 4(12):1683-1690. PubMed ID: 30286235
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Statins are associated with a reduced risk of hepatocellular carcinoma in a large cohort of patients with diabetes.
    El-Serag HB; Johnson ML; Hachem C; Morgana RO
    Gastroenterology; 2009 May; 136(5):1601-8. PubMed ID: 19208359
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Meta-analysis: Chemoprevention of hepatocellular carcinoma with statins, aspirin and metformin.
    Zeng RW; Yong JN; Tan DJH; Fu CE; Lim WH; Xiao J; Chan KE; Tan C; Goh XL; Chee D; Syn N; Tan EX; Muthiah MD; Ng CH; Tamaki N; Lee SW; Kim BK; Nguyen MH; Loomba R; Huang DQ
    Aliment Pharmacol Ther; 2023 Mar; 57(6):600-609. PubMed ID: 36625733
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Statin Use After Diagnosis of Hepatocellular Carcinoma Is Associated With Decreased Mortality.
    Thrift AP; Natarajan Y; Liu Y; El-Serag HB
    Clin Gastroenterol Hepatol; 2019 Sep; 17(10):2117-2125.e3. PubMed ID: 30625400
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Statin use is associated with a reduced risk of hepatocellular carcinoma recurrence after initial liver resection.
    Kawaguchi Y; Sakamoto Y; Ito D; Ito K; Arita J; Akamatsu N; Kaneko J; Hasegawa K; Moriya K; Kokudo N
    Biosci Trends; 2017 Nov; 11(5):574-580. PubMed ID: 29081488
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.